C2ORF29 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.637800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.312200E-01
Normal-vs-Stage2
5.710400E-01
Normal-vs-Stage3
2.011200E-01
Normal-vs-Stage4
4.268000E-01
Stage1-vs-Stage2
9.105200E-01
Stage1-vs-Stage3
1.500020E-01
Stage1-vs-Stage4
6.498400E-01
Stage2-vs-Stage3
3.188300E-02
Stage2-vs-Stage4
3.720000E-01
Stage3-vs-Stage4
1.251200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.720400E-01
Normal-vs-AfricanAmerican
8.141000E-01
Normal-vs-Asian
3.740400E-01
Caucasian-vs-AfricanAmerican
7.700200E-01
Caucasian-vs-Asian
3.706200E-01
AfricanAmerican-vs-Asian
4.008600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.695400E-01
Normal-vs-Female
7.913400E-01
Male-vs-Female
2.201800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.763200E-01
Normal-vs-Age(41-60Yrs)
4.389200E-01
Normal-vs-Age(61-80Yrs)
7.648200E-01
Normal-vs-Age(81-100Yrs)
6.397800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.641800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.132200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.557600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.104000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.267400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.209800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.904800E-01
Normal-vs-Daily Drinker
9.844200E-01
Normal-vs-Weekly Drinker
6.598600E-01
Normal-vs-Occasional Drinker
1.780630E-01
Normal-vs-Social Drinker
9.053400E-01
Non Drinker-vs-Daily Drinker
3.677600E-01
Non Drinker-vs-Weekly Drinker
9.622200E-01
Non Drinker-vs-Occasional Drinker
1.889970E-01
Non Drinker-vs-Social Drinker
5.001600E-01
Daily Drinker-vs-Weekly Drinker
4.095000E-01
Daily Drinker-vs-Occasional Drinker
2.588300E-02
Daily Drinker-vs-Social Drinker
8.398000E-01
Weekly Drinker-vs-Occasional Drinker
2.462200E-01
Weekly Drinker-vs-Social Drinker
4.833400E-01
Occasional Drinker-vs-Social Drinker
2.470400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.065900E-02
Normal-vs-Grade 2
1.092170E-02
Normal-vs-Grade 3
7.055600E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.770200E-02
Grade 1-vs-Grade 3
1.290480E-02
Grade 1-vs-Grade 4
8.065900E-02
Grade 2-vs-Grade 3
3.809400E-01
Grade 2-vs-Grade 4
1.092170E-02
Grade 3-vs-Grade 4
7.055600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.040600E-01
Normal-vs-NonDiabetic
6.052800E-01
Diabetic-vs-NonDiabetic
2.465600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.359400E-01
Normal-vs-NoPancreatitis
7.531000E-01
Pancreatitis-vs-NoPancreatitis
3.796000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.735400E-01
Normal-vs-N1
6.272600E-01
N0-vs-N1
6.873600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.090830E-01
Normal-vs-TP53-NonMutant
8.050200E-01
TP53-Mutant-vs-TP53-NonMutant
1.351410E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
